Stock listing

NASDAQ:AMLN Amylin Pharmaceuticals LLC Stock

Follow Amylin Pharmaceuticals LLC into a list and get an email when it puts out news.

Last close · NASDAQ:AMLN

$30.98 USD

Close on Aug 8, 2012 · No longer trades

Dec 31, 1997 to last close +469.7% · monthly closes, Dec 31, 1997 – Aug 8, 2012
Lowest – highest close
$0.313 – $51.43 USDSince Dec 31, 1997 · lowest Oct 23, 1998 · highest Aug 9, 2007

Delisted NASDAQ:AMLN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AMLN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Amylin Pharmaceuticals LLC on 6ix

Decks
7 decks · latest Nov 8, 2011

Decks

DeckKindSlidesDate
Merger or Acquisition (November 2011)Merger or acquisition29 slidesNov 8, 2011
Proxy Contest (May 2009)Proxy contest8 slidesMay 14, 2009
Proxy Contest (May 2009)Proxy contest7 slidesMay 11, 2009
Proxy Contest (May 2009)Proxy contest33 slidesMay 5, 2009
Proxy Contest (May 2009)Proxy contest43 slidesMay 5, 2009
Q1 2009 Earnings PresentationEarnings14 slidesApr 16, 2009
Cowen and Company 29th Annual Health Care Conference 2009Conference15 slidesMar 17, 2009

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Vaughn D Bryson
Other companies: Pharmaceutical Product Development Inc (Director · May 18, 2011 – Dec 5, 2011 · Past); Icos Corp (Director · May 11, 2006 – Jan 29, 2007 · Past); Atherogenics Inc (Director · Apr 26, 2006 – May 22, 2008 · Past)
Director · Dec 31, 2005 – Apr 17, 2007 · Past
Christian Weyer
Other companies: Intercept Pharmaceuticals Inc (EVP, Research & Development · Nov 27, 2017 – Apr 1, 2021 · Past); Fate Therapeutics, Inc. (See Remarks, Director · Sep 30, 2013 – Apr 13, 2015 · Past)
SVP, Research & Development · Jun 1, 2010 – Feb 22, 2012 · Past
James R Gavin III
Other companies: Baxalta Inc (Director · Jul 1, 2015 – Jun 3, 2016 · Past); Baxter International Inc. (Director · Apr 19, 2010 – Sep 11, 2020 · Past)
Director · Apr 5, 2010 – Aug 8, 2012 · Past
Lloyd A Rowland
Other companies: CytomX Therapeutics, Inc. (General Counsel · Jun 13, 2018 – Mar 18, 2025 · Past); Xencor, Inc. (Sr. V.P. and General Counsel · Aug 29, 2014 – Jan 26, 2016 · Past)
VP, Chief Compliance Officer · Dec 30, 2005 – Aug 8, 2012 · Past
James N. Wilson
Other companies: Corcept Therapeutics Incorporated (CHAIRMAN OF THE BOARD · Since at least Nov 11, 2008)
Director · Oct 3, 2008 – Apr 3, 2009 · Past
Marcea Bland Lloyd
Other companies: Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past)
SVP, Chief Administrative Offi · Mar 1, 2011 – Feb 8, 2012 · Past
Terrance H Gregg
Other companies: DexCom, Inc. (Former Executive Chairman, Director · Jan 3, 2006 – Jul 30, 2018 · Past)
Director · Dec 31, 2005 – Apr 5, 2006 · Past
Thomas R Testman
Other companies: Endocare Inc (Director · Jan 10, 2006 – May 15, 2009 · Past)
Director · Dec 31, 2005 – Jun 1, 2007 · Past
Orville G KoltermanSVP, Chief Medical Officer · Feb 3, 2009 – Feb 22, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Amylin Pharmaceuticals LLC.